Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study.
Kherabi Y, Skouvig Pedersen O, Lange C, Bénézit F, Chesov D, Codecasa LR, Dudnyk A, Kiria N, Konstantynovska O, Marigot-Outtandy D, Panciu TC, Poignon C, Sasi S, Schaub D, Solodovnikova V, Vasiliauskaitè L, Yeghiazaryan L, Günther G, Guglielmetti L; TBnet/ESGMYC XDR-TB Study Group.
Kherabi Y, et al.
Lancet Reg Health Eur. 2025 Jul 15;56:101380. doi: 10.1016/j.lanepe.2025.101380. eCollection 2025 Sep.
Lancet Reg Health Eur. 2025.
PMID: 40697337
Free PMC article.